Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

Military Labs Use Whole Genome Sequencing of COVID-19 Variants

Image of Lab technician at work. A lab technician at the Naval Health Research Center prepares samples for whole genome sequencing. The DOD SARS-CoV-2 Whole Genome Sequencing Action Plan brings together laboratories to conduct whole genome sequencing across the Military Health System in response to the COVID-19 pandemic.

Editor's note: This is the first article in a 7-part series that highlights the work of technicians and scientists working in service laboratories that support the Military Health System, and who worked to identify COVID-19 variants using special sequencing technology.

A Department of Defense SARS-CoV-2 Whole Genome Sequencing Action Plan for the Military Health System was developed in response to the COVID-19 pandemic and signed on June 25. The plan brings together the service laboratories to conduct whole genome sequencing across the MHS.

Under this plan, the Under Secretary of Defense for Personnel and Readiness endorsed the efforts of five stateside laboratories and five overseas laboratories who sequenced a large volume of SARS-CoV-2 samples since June 2021. These laboratories also contributed to the rapid detection and reporting of SARS-CoV-2 variant emergence and distribution among MHS beneficiaries. Since the beginning of the pandemic in March 2020, the laboratories have received 39,640 samples for sequencing, with 93% of sequenced samples among active duty service members.

"The Armed Forces Health Surveillance Division, and particularly the Global Emerging Infections Surveillance Branch, have provided critical support to near-real time surveillance at the point of impact in various global communities. GEIS was critical in leading the expansion of this capability to mitigate any new biology health threats that may impact our service members," said AFHSD's chief and U.S. Air Force Col. Patrick W. Kennedy.

The results of this sequencing will benefit individual service members and local communities.

"WGS is a valuable research tool that has many applications. During this critical time, the most important role it plays is in the detection of clinical pathogen mutations. If a virus is detected, the WGS process will allow the clinical community to mitigate the more virulent or transmissible virus with additional protective measures," said Kennedy.

The laboratories will continue to work together to collect and sequence samples to monitor variant emergence, identify and respond to outbreaks, and describe the frequency of COVID-19 infections in DOD-relevant populations into the future.

"Information sharing is a critical force multiplier that will allow us to produce better outcomes as we face potential pandemics. The coordination and rapid identification used in the WGS plan will help to determine spread and protect potentially vulnerable populations for the safety of our operational forces," said Kennedy.

To learn more about these efforts, the Defense Health Agency will post a series of short stories to highlight the joint effort of our service laboratories. Labs highlighted will include:

You also may be interested in...

Policy
Aug 18, 2022

DHA Policy Memo 22 006

.PDF | 156.56 KB

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

  • Identification #: 22-006
  • Type: Memorandums
Policy
Mar 25, 2021

TAB A MEO COVID19 Medical Coding Policy

.PDF | 161.81 KB

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Type: Memorandums
Policy
Mar 25, 2021

DHA COVID19 Medical Coding PolicyV5 1v

.PDF | 436.92 KB

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Type: Memorandums
Policy
Dec 31, 2020

Providing DoD COVID 19 Vaccines DoD Contractors and Select Foreign Nationals

.PDF | 129.54 KB

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

  • Identification #: N/A
  • Type: Memorandums
Policy
Dec 17, 2020

Guidance for COVID 19 Laboratory Pre Testing Questionnaire

.PDF | 574.09 KB

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

  • Identification #: N/A
  • Type: Memorandums
Policy
Dec 7, 2020

Coronavirus Disease 2019 Vaccine Guidance

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Type: Memorandums
Policy
Nov 3, 2020

DHA AI 3020 01

.PDF | 846.31 KB

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

  • Identification #: 3020.01
  • Type: Administrative Instructions
Policy
May 13, 2020

DHA Policy Memo 20 003

.PDF | 354.70 KB

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum ...

  • Identification #: 20-003
  • Type: Memorandums
Policy
Jul 26, 2012

Guidance on the Establishment of a Human Cell Tissue and Cellular and Tissue Based Products Progra

.PDF | 1017.00 KB

This memorandum requests the Services resource a Human Cell, Tissue, and Cellular and Tissue Based Products (HCT/Ps) Program that complies with regulatory standards for management and oversight of HCT/Ps, according to the best fit for their Service.

  • Identification #: 00-memo-2012-07-26
  • Type: Memorandums
Refine your search
Last Updated: July 11, 2023
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery